A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00768339
Recruitment Status : Terminated (Slow recruitment)
First Posted : October 8, 2008
Last Update Posted : July 13, 2011
The Leukemia and Lymphoma Society
Information provided by:
Aegera Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2011
  Estimated Study Completion Date : September 2011